Osteoporosis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• RANKL 1
• PI3K 0
• NRF2 0
• AKT 0
• CTNNB1 0
• MAPK 0
• SIRT1 0
• mTOR 0
• AMPK 0
• PPAR 0
• STAT3 0
• ERK 0
• NLRP3 0
• YAP 0
• GPX4 0
• GLP-1 1
• TP53 0
• STING 0
• TNF 0
• HIF-1 0
• JAK 0
• METTL3 0
• IL-6 0
• PTEN 0
• VEGF 0
• CXCR4 0
• JNK 0
• MMP-9 0
• ESR1 0
• IL-4 0
• MEK 0
• PINK1 0
• SGLT2 0
• APP 0
• COX-2 0
• CSF1R 0
• DPP-4 0
• FTO 0
• HMGB1 0
• IL-1 0
• KIT 1
• APOE 0
• CD40 0
• CGRP 0
• EGFR 0
• EZH2 0
• FOXP3 0
• MYC 0
• TFEB 0
• ACE2 0
• AXL 0
• BRAF 0
• BRCA1 0
• BRCA2 0
• BRD4 0
• CCR5 0
• CDK4/6 0
• FGFR 0
• G6PD 0
• HSP90 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Telerehabilitation Versus Traditional Balance Training in Women With Osteoporosis.

  NCT07148479· Riphah International University· Updated 27 Aug 2026

  “Unavailability of patients and other resources to the researchers”Registry text, quoted unchanged. Source

• Withdrawn

  Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis

  NCT05060380· University of Alabama at Birmingham· Updated 1 Jul 2026

  “The study was never started.”Registry text, quoted unchanged. Source

• Withdrawn

  EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

  NCT05998863· University of Texas Southwestern Medical Center· Updated 30 Jun 2026

  “No enrollment due to COVID”Registry text, quoted unchanged. Source

• Withdrawn

  Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

  NCT06973109· University of Pittsburgh· Updated 4 Jun 2026

  “Investigator left the institution”Registry text, quoted unchanged. Source

• Suspended

  Low Frequency Ultrasound for Osteoarthritis Healing and Rehabilitation

  NCT06562374· The University of Texas Medical Branch, Galveston· Updated 6 Mar 2026

  “Suspended by IRB”Registry text, quoted unchanged. Source

• Withdrawn

  Comparison of the Effectiveness of a Web Fracture Liaison Service (e_FLS) to Fracture Liaison Services in France: the evAB Study (evAB)

  NCT05303350· Assistance Publique - Hôpitaux de Paris· Updated 20 Nov 2025

  “logistic difficulties”Registry text, quoted unchanged. Source

• Terminated

  Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging

  NCT04669782· University of Milano Bicocca· Updated 29 Jul 2025

  “Logistics/management problems at the recruiting center”Registry text, quoted unchanged. Source

• Withdrawn

  Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®

  NCT06504966· Xentria, Inc.· Updated 11 May 2025

  “Business decision not to proceed with the study.”Registry text, quoted unchanged. Source

• Withdrawn

  Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis

  NCT05152381· The Foundation for Orthopaedics and Regenerative Medicine· Updated 8 Apr 2025

  “Difficulty Recruiting Participants”Registry text, quoted unchanged. Source

• Terminated

  RCT of Vibration Effect on Vertebral BMD in Disabled Patients

  NCT04180267· Chinese University of Hong Kong· Updated 14 Feb 2025

  “Discontinued due to COVID, community centres unable to provide services”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Romosozumab and Denosumab Combination Therapy for Osteoporosis

  NCT07909304· Massachusetts General Hospital· Source

• Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes

  NCT06745544· Aalborg University Hospital· Source

• Quanduzhong Capsules for Primary Osteoporosis

  NCT07895082· Shanghai University of Traditional Chinese Medicine· Source

• A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

  NCT05067335· UCB Biopharma SRL· Source

• Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans

  NCT07739628· Union Hospital, Tongji Medical College, Huazhong University of Science and Technology· Source

• Novel Combination Therapy for Osteoporosis in Men

  NCT03994172· VA Office of Research and Development· Source

• GLP-1R Actions on Muscle and the Skeleton

  NCT07154719· Pennington Biomedical Research Center· Source

• A Study of Romosozumab in People With Breast Cancer and Osteoporosis

  NCT07776613· Memorial Sloan Kettering Cancer Center· Source

• Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

  NCT07772609· Sahlgrenska University Hospital· Source

• OSTEOMICS: Identifying Regulators of Bone Homeostasis

  NCT05732870· Relation Therapeutics· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 17
• Organoids 1
• Mendelian Randomization Analysis 90
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 1
• Exome Sequencing 6
• Proteomics 22
• Metabolomics 25
• Mass Spectrometry 7
• Flow Cytometry 6
• Immunohistochemistry 10
• Xenograft Model Antitumor Assays 3
• Magnetic Resonance Imaging 72
• Machine Learning 79
• Deep Learning 38
• Cohort Studies 236
• Genome-Wide Association Study 82

• OsteoNet-X: A deep residual learning framework for automated osteoporosis detection from knee X-ray images.

  PLoS One, Oct 2026

• Cost-utility analysis of deep learning-based opportunistic osteoporosis screening using chest radiographs: implications of diagnostic thresholds and confirmatory testing.

  Arch Osteoporos, Oct 2026

• IgeaNet: a deep learning model for opportunistic osteoporosis screening from chest X-ray images.

  Radiol Med, Sept 2026

• Optimizing deep learning-enhanced opportunistic osteoporosis screening from chest X-rays in Australia: Impact of follow-up and treatment adherence on clinical and economic outcomes.

  Bone, Sept 2026

• Screening opportunistic osteoporosis through multimodal techniques of hip joint CT images: exploring 2D and 3D deep learning, radiomics, clinical data, and their integration.

  Front Endocrinol (Lausanne), Jul 2026

• Deep Learning for Opportunistic Vertebral Fracture Detection on Routine Thoraco-abdominal Computed Tomography: A Systematic Review and Hierarchical Summary Receiver Operating Characteristic Meta-analysis of Patient-level Diagnostic Test Accuracy.

  Acad Radiol, Jun 2026

• Computer-aided diagnosis system for thoracic computed tomography of rib fractures in older emergency patients: A preliminary study.

  PLoS One, Jun 2026

• Opportunistic Screening for Low Bone Density Using Automated Vertebral Trabecular CT Attenuation from Low-Dose CT Acquired During FDG PET/CT: A Single-Center Retrospective Study.

  Tomography, Jun 2026

• Deep Learning-Assisted Radiomics for Predicting Thoracolumbar Osteoporotic Vertebral Fractures.

  Clin Interv Aging, May 2026

• MultiScaleKANNet: a hybrid CNN-KAN-transformer architecture for radiographic bone-loss risk stratification from knee X-rays.

  Sci Rep, May 2026

See which targets of this disease your abstract mentions, and go to the people working on them.